(b)(4).This follow-up report is being submitted to relay additional information.D10: revitanâ®, proximal part, cylindrical, uncemented, 95, taper 12/14, item# 01.00402.095, lot# 2774766.Product evaluation: no product was returned or pictures provided: product evaluation could not be performed.Device history record (dhr) review: review of the device history records identified no deviations or anomalies during manufacturing.Devices are used for treatment.Medical radiographs were provided and reviewed by a health care professional.Review of the available records identified the following: fracture of the right femoral implant as noted possibly resulting from an aggressive twisting injury.Bone quality shows marked ssteopenia.The complaint reports a fracture of the revitan shaft while patient turned on the spot.On item was a field safety notice was provided to emphasize that patient selection for modular hip revision systems is a key parameter and bone stock of adequate quality must be present and appraised at the time of surgery.The product at hand was implanted prior to this field action.As reported in the medical records review, the patients shows bone quality markedly osteopenic.The condition of the patient at the moment of the surgery might be a contributor factor to the adverse event.However, no further data are available and the product was not returned for evaluation.Therefore, with the given information, a definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental report will be filed accordingly.Zimmer biomet will continue to monitor for trends.
|